Wallisch Michael, Nelson Cole S, Mulvaney Julia M, Hernandez Heather S, Smith Sue Ann, Olsen George D
Department of Physiology and Pharmacology, School of Medicine, 3181 SW Sam Jackson Park Road, Oregon Health and Science University, Portland, OR 97239, USA.
Biochem Pharmacol. 2007 Jun 1;73(11):1818-28. doi: 10.1016/j.bcp.2007.02.001. Epub 2007 Feb 12.
Chronic opioid treatment leads to agonist-specific effects at the mu opioid receptor. The molecular mechanisms resulting from chronic opioid exposure include desensitization, internalization and down-regulation of membrane-bound mu opioid receptors (MOP). The purpose of this study was to compare the cellular regulation of guinea pig, human and rat MOP expressed in Chinese hamster ovary (CHO) cells, following exposure to two clinically important opioids, morphine and methadone. MOP expressing CHO cells were treated in culture with methadone or morphine for up to 48 h. Radioligand diprenorphine and [D-AIa(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin (DAMGO)-stimulated GTP gamma S binding assays were carried out using paired control and opioid-exposed CHO cells. Methadone induced downregulation of the mu opioid receptor, while morphine induced desensitization of the receptor for all three species. Furthermore, morphine predominantly decreased the potency of DAMGO to stimulate GTP gamma S binding, whereas methadone primarily reduced its efficacy. Changes in DAMGO potency and efficacy differed among species and depended on the opioid used to treat the cells. Our results showed similarities between guinea pig and human MOP for morphine-induced desensitization, but identified differences between the two for methadone-induced desensitization. In contrast, human and rat MOP differed in response to morphine treatment, but were not distinct in their response to methadone treatment. The guinea pig is an excellent and established animal model to study opioid effects, but its molecular opioid pharmacology has not been investigated thus far. These results can assist in understanding species differences in the effects of opioid ligands activating the mu opioid receptor.
慢性阿片类药物治疗会导致μ阿片受体产生激动剂特异性效应。慢性阿片类药物暴露所产生的分子机制包括膜结合型μ阿片受体(MOP)的脱敏、内化和下调。本研究的目的是比较在暴露于两种临床重要阿片类药物——吗啡和美沙酮后,中国仓鼠卵巢(CHO)细胞中表达的豚鼠、人及大鼠MOP的细胞调节情况。表达MOP的CHO细胞在培养中用美沙酮或吗啡处理长达48小时。使用配对的对照和阿片类药物处理的CHO细胞进行放射性配体二丙诺啡和[D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-脑啡肽(DAMGO)刺激的GTPγS结合试验。美沙酮诱导μ阿片受体下调,而吗啡诱导所有三种物种的受体脱敏。此外,吗啡主要降低DAMGO刺激GTPγS结合的效力,而美沙酮主要降低其效能。DAMGO效力和效能的变化在不同物种间存在差异,且取决于用于处理细胞的阿片类药物。我们的结果显示,豚鼠和人MOP在吗啡诱导的脱敏方面具有相似性,但在美沙酮诱导的脱敏方面存在差异。相比之下,人和大鼠MOP对吗啡治疗的反应不同,但对美沙酮治疗的反应没有明显差异。豚鼠是研究阿片类药物效应的优秀且成熟的动物模型,但迄今为止尚未对其分子阿片类药物药理学进行研究。这些结果有助于理解激活μ阿片受体的阿片类配体效应的物种差异。